WaveMan · Form 4
Sandler Alan B. insider trades
> Search tickers & screens ⌘K
LIVE

Sandler Alan B. insider trades

Sandler Alan B. has filed 18 Form 4s with the SEC that we hold, for Alx Oncology Holdings INC (ALXO) (Director), ELEV (Director), MRTX (Chief Medical Officer) and Zai Lab Ltd (ZLAB) (Head of Global Dev., Oncology), among 5 companies in all. Across all of them we count 0 purchases worth $0 and 7 sales worth $1.3M reported on Form 4. In the last 12 months: 0 purchases ($0) and 7 sales ($1.3M). The largest single trade was a sale of 2,200 shares of Revolution Medicines, Inc. worth $441.8K, dated 2026-09-29. Of 7 sales filed since we began reading the 10b5-1 checkbox, 7 (100%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2021-12-03 and the latest 2026-10-01.

Alx Oncology Holdings INC (ALXO)

Director · 5 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

ELEV (ELEV)

Director · 4 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

MRTX

Chief Medical Officer · 4 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Zai Lab Ltd (ZLAB)

Head of Global Dev., Oncology · 3 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Revolution Medicines, Inc. (RVMD)

Chief Development Officer · 2 filings · 7 purchases and sales
Trade dateCodeSharesValue as filedFiled
2026-09-16S, sale reported on Form 45$9752026-09-18
2026-09-16S, sale reported on Form 4336$67.0K2026-09-18
2026-09-29S, sale reported on Form 42,200$441.8K2026-10-01
2026-09-29S, sale reported on Form 41,609$324.6K2026-10-01
2026-09-29S, sale reported on Form 41,000$202.8K2026-10-01
2026-09-29S, sale reported on Form 41,199$244.5K2026-10-01
2026-09-29S, sale reported on Form 4301$61.6K2026-10-01
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1835966) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms